{"B-Claim": ["Erlotinib", "Epoetin","Despite","Vinorelbine","Oral","Future","Additional","Combined","Thalidomide","Hot","Postoperative","Medical","Radiotherapy","Abiraterone"], 
"B-Premise": ["Median","Toxicity","Results","Fatigue","Global","Improvements","Comparing","Severe","Complete","PFS","Improvement"], 
"I-Claim": ["advanced","effective","improve","associated","symptoms","women","NSCLC","improved","clinical"], 
"I-Premise": ["P","95","arm","respectively","difference","groups","scores","vs","versus","differences","001"]}
